Loading...
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
BACKGROUND: Monoamine oxidase inhibitors (MAOIs) are being developed for major depressive disorder, Alzheimer’s, and Parkinson’s Disease. Newer MAOIs have minimal sensitivity to tyramine, but a key limitation for optimizing their development is that standards for in vivo monoamine oxidase-A (MAO-A)...
Na minha lista:
| Udgivet i: | Int J Neuropsychopharmacol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772270/ https://ncbi.nlm.nih.gov/pubmed/26316187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyv078 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|